Fangmeng Fu
Overview
Explore the profile of Fangmeng Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Expression and Subtype Discordance Between Core Needle Biopsy and Surgical Specimen in Breast Cancer
Xu M, Yan Y, Chen Y, Chen X, Gong K, Fu F
J Surg Res
. 2025 Feb;
307:42-52.
PMID: 39985907
Introduction: Estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptors 2 (HER2s) are crucial for the molecular subtype classification and therapy decision-making in breast cancer. Core needle...
2.
Lin Y, Zhang Q, Chen H, Liu S, Peng K, Wang X, et al.
BMC Med
. 2025 Feb;
23(1):97.
PMID: 39984977
Background: Early detection of cancer can help patients with more effective treatments and result in better prognosis. Unfortunately, established cancer screening technologies are limited for use, especially for multi-cancer early...
3.
Xu Y, Cai Q, Li J, Guo W, Chen L, Chen M, et al.
Breast Cancer Res Treat
. 2025 Jan;
PMID: 39755988
Purpose: Age stratification influences the clinicopathological features and survival outcomes of breast cancer. We aimed to understand the effect of age on gene variants in young Chinese women with breast...
4.
Zhao D, Yu X, Huang H, Zou S, Zhu P, Lin Y, et al.
Front Oncol
. 2024 Dec;
14:1475979.
PMID: 39703847
Background: Chemokines are well-known for playing an essential role in the development of cancer. However, the association between SNPs in the CCL2 and CXCL12 genes and the susceptibility to breast...
5.
Chen X, Cai Q, Deng L, Chen M, Xu M, Chen L, et al.
Front Immunol
. 2024 Dec;
15:1465862.
PMID: 39628488
Introduction: The association between inflammatory blood markers (IBMs) (monocyte-to-lymphocyte ratio [MLR], neutrophil-to-lymphocyte ratio [NLR], and platelet-to-lymphocyte ratio [PLR]) and breast cancer has been extensively studied. However, the predictive role of...
6.
Nie Q, Zhang W, Lin S, Huang M, Li Y, Qiu Y, et al.
Cancer Sci
. 2024 Oct;
115(12):4064-4073.
PMID: 39401980
Mitochondrial DNA (mtDNA) variations affect the efficiency of the electron transport chain and production of reactive oxygen species, contributing to carcinogenesis. The D-loop region of mtDNA has emerged as a...
7.
Li Y, Lin Y, Tang Y, Jiang M, Chen X, Chen H, et al.
Cell Death Dis
. 2024 Jul;
15(7):516.
PMID: 39025830
Tumour metabolic reprogramming is pivotal for tumour survival and proliferation. Investigating potential molecular mechanisms within the heterogeneous and clinically aggressive triple-negative breast cancer (TNBC) subtype is essential to identifying novel...
8.
Li J, He P, Cai Q, Chen L, Wang Y, Cai W, et al.
J Cancer Res Clin Oncol
. 2024 Jun;
150(6):322.
PMID: 38914840
Purpose: Limited data are available regarding the partner and localizer of BRCA2 (PALB2) in Chinese patients with early breast cancer. This study aimed to assess the spectrum and characteristics of...
9.
Lin Y, Li Y, Chen X, Jin X, Jiang M, Xiao H, et al.
Biol Direct
. 2024 Jun;
19(1):42.
PMID: 38831379
Triple-negative breast cancer (TNBC) is more aggressive and has a higher metastasis rate compared with other subtypes of breast cancer. Due to the lack of drug-targetable receptors, chemotherapy is now...
10.
Chen H, Chen M, Zeng B, Tang L, Nie Q, Jin X, et al.
Front Immunol
. 2024 May;
15:1284579.
PMID: 38690279
Introduction: The programmed cell death (PCD) pathway plays an important role in restricting cancer cell survival and proliferation. However, limited studies have investigated the association between genetic variants in the...